Terms: = Prostate cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
19 results:
1. Research of the unrecognised functions of miR-375 in prostate cancer cells.
Goztepe M; Eroglu O
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):212-218. PubMed ID: 38650131
[TBL] [Abstract] [Full Text] [Related]
2. CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells.
Liu S; Chen X; Zhang L; Lu B
Cancer Biol Ther; 2024 Dec; 25(1):2329372. PubMed ID: 38494680
[TBL] [Abstract] [Full Text] [Related]
3. High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer.
Meng J; Ruan X; Wei F; Xue Q
Medicine (Baltimore); 2023 Aug; 102(31):e34480. PubMed ID: 37543832
[TBL] [Abstract] [Full Text] [Related]
4. Construction of lncRNA/Pseudogene-miRNA Network Based on In Silico Approaches for Glycolysis Pathway to Identify prostate Adenocarcinoma-Related Potential Biomarkers.
Khorsand M; Mostafavi-Pour Z; Tahmasebi A; Omidvar Kordshouli S; Mousavi P
Appl Biochem Biotechnol; 2024 Apr; 196(4):2332-2355. PubMed ID: 37542606
[TBL] [Abstract] [Full Text] [Related]
5. Contribution of the L-Type Amino Acid Transporter Family in the diagnosis and Treatment of prostate cancer.
Zhao X; Sakamoto S; Wei J; Pae S; Saito S; Sazuka T; Imamura Y; Anzai N; Ichikawa T
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047148
[TBL] [Abstract] [Full Text] [Related]
6. The roles and mechanisms of circular RNAs related to mtor in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
7. Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical prostate cancer Treatment: A Pan prostate cancer Group Study.
Burns D; Anokian E; Saunders EJ; Bristow RG; Fraser M; Reimand J; Schlomm T; Sauter G; Brors B; Korbel J; Weischenfeldt J; Waszak SM; Corcoran NM; Jung CH; Pope BJ; Hovens CM; Cancel-Tassin G; Cussenot O; Loda M; Sander C; Hayes VM; Dalsgaard Sorensen K; Lu YJ; Hamdy FC; Foster CS; Gnanapragasam V; Butler A; Lynch AG; Massie CE; ; Woodcock DJ; Cooper CS; Wedge DC; Brewer DS; Kote-Jarai Z; Eeles RA
Eur Urol; 2022 Aug; 82(2):201-211. PubMed ID: 35659150
[TBL] [Abstract] [Full Text] [Related]
8. Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.
Amin M; Gao F; Terrero G; Picus J; Wang-Gillam A; Suresh R; Ma C; Tan B; Baggstrom M; Naughton MJ; Trull L; Belanger S; Fracasso PM; Lockhart AC
Am J Clin Oncol; 2021 Sep; 44(9):443-448. PubMed ID: 34310349
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
[TBL] [Abstract] [Full Text] [Related]
10. Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins.
Noé V; Aubets E; Félix AJ; Ciudad CJ
Biochem Pharmacol; 2021 Jul; 189():114371. PubMed ID: 33338475
[TBL] [Abstract] [Full Text] [Related]
11. TGF-β/PI3K/AKT/mtor/NF-kB pathway. Clinicopathological features in prostate cancer.
Torrealba N; Vera R; Fraile B; Martínez-Onsurbe P; Paniagua R; Royuela M
Aging Male; 2020 Dec; 23(5):801-811. PubMed ID: 30973040
[TBL] [Abstract] [Full Text] [Related]
12. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O; Kouri M; Papadopoulou E; Vardas E; Galiti D; Epstein JB; Elad S; Campisi G; Tsoukalas N; Bektas-Kayhan K; Tan W; Body JJ; Migliorati C; Lalla RV;
Support Care Cancer; 2019 Feb; 27(2):383-394. PubMed ID: 30353228
[TBL] [Abstract] [Full Text] [Related]
13. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mtor signaling pathway.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
[TBL] [Abstract] [Full Text] [Related]
14. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.
Sailo BL; Banik K; Padmavathi G; Javadi M; Bordoloi D; Kunnumakkara AB
Pharmacol Res; 2018 Apr; 130():259-272. PubMed ID: 29496592
[TBL] [Abstract] [Full Text] [Related]
15. Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.
Khakshour S; Labrecque MP; Esmaeilsabzali H; Lee FJS; Cox ME; Park EJ; Beischlag TV
Sci Rep; 2017 Aug; 7(1):7833. PubMed ID: 28798482
[TBL] [Abstract] [Full Text] [Related]
16. Genetics meets pathology - an increasingly important relationship.
Bonthron DT; Foulkes WD
J Pathol; 2017 Jan; 241(2):119-122. PubMed ID: 27859271
[TBL] [Abstract] [Full Text] [Related]
17. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract] [Full Text] [Related]
18. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.
Piselli P; Serraino D; Segoloni GP; Sandrini S; Piredda GB; Scolari MP; Rigotti P; Busnach G; Messa P; Donati D; Schena FP; Maresca MC; Tisone G; Veroux M; Sparacino V; Pisani F; Citterio F;
Eur J Cancer; 2013 Jan; 49(2):336-44. PubMed ID: 23062667
[TBL] [Abstract] [Full Text] [Related]
19. Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.
Renner O; Fominaya J; Alonso S; Blanco-Aparicio C; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1418-25. PubMed ID: 17372272
[TBL] [Abstract] [Full Text] [Related]